- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06344676
Study of the Impact of a Social Robot on Unwanted Loneliness in Elderly People Living in Nursing Homes (WITHPEPPER)
Estudi de l'Impacte de la Soledat no Volguda Incorporant un Robot Social en Centres Residencials
The goal of this clinical trial is to assess the usefulness of social robots reducing unwanted loneliness in persons over 65 living in nursing homes. The main questions it aims to answer are:
- Can social robots reduce unwanted loneliness?
- Can social robots improve quality of live and well-being? The selected centers are organized in several classes of living units. Living units are independent physical spaces with their own common facilities for the persons living in (usually around 15). Living units of the same class gather persons with similar characteristics.
To compare the added value of the robots half of the living units will be allocated to a control group, and the other half to the intervention group.
The persons in living units allocated to the control group will receive the same attentions and care which were receiving before the enrollment in the study, whereas the persons allocated to the intervention group will add a social robot to their usual therapies and activities. Namely participants will do three weekly individual cognitive stimulation sessions of 10 minutes each one, two weekly group mobility sessions of 30 minutes, one monthly conversational group about customs and traditions of 60 minutes, one 10 minutes videoconference per month with their relatives. Furthermore, participants will be able to interact freely with the robot to obtain information about the center (for instance, what is for dinner) and its activities.
The intervention will last 8 weeks. To assess the effectivity, the investigators will assess both groups, before the intervention, at the end of the intervention and 4 weeks after finishing the intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara Domenech Pou, PhD
- Phone Number: +34 934464517
- Email: sara.domenech@uab.cat
Study Contact Backup
- Name: Nuria Infiesta
- Phone Number: +34 649646805
- Email: ninfiesta@yasyt.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- To be 65 years old or older.
- To live indefinitely for more than 6 months in the participating nursing home (to avoid the effect of the adaptation period).
- Provide the informed consent.
Exclusion Criteria:
- Impossibility to understand and/or answer the loneliness questionnaire for themselves.
- To have physical, cognitive or other conditions preventing the use of the robot platform.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual Care
This group will do the usual therapies and activities that were doing before the enrolment in the study
|
Attentions and treatments received by the persons before the enrollment in the study.
|
|
Experimental: Robot
This group will do the usual therapies and activities that were doing before the enrolment in the study plus:
|
Attentions and treatments received by the persons before the enrollment in the study.
Tree 10 minutes individual sessions per week involving memory, attention and executive functions tasks.
Two 30 minutes group session per week involving physical activity assisted by a social robot.
One 60 minutes group session per month assisted by a social robot that facilitates talking about costumes and traditions.
Unrestricted individual interaction of the user with the Pepper robot to obtain information of interest for the user (menu, time, date, place and calendar of activities of the residential.
center) and 1 individual monthly videoconference with the family of 10 minutes of duration.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Loneliness
Time Frame: weeks 0, 8 and 12
|
Change in the UCLA Loneliness Scale (Version 3).
The UCLA Loneliness Scale is a 20-item scale (Russell, 1996) that includes statements (e.g., How often do you feel alone?)
rated on a four-point Likert scale ranging from 1 (never) to 4 (always).
The total score ranges from 20 to 80. Higher scores indicate greater degrees of loneliness.
|
weeks 0, 8 and 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Well-being
Time Frame: weeks 0, 8 and 12
|
Change in the World Health Organisation- Five Well-Being Index (WHO-5).The WHO-5 is a short, self-administered measure of well-being over the last two weeks.
It consists of five positively worded items that are rated on 6-point Likert scale, ranging from 0 (at no the time) to 5 (all of the time).
The total score ranges from 0 to 100, with lower scores indicating worse well-being.
|
weeks 0, 8 and 12
|
|
Quality of life, irrespective of the disease
Time Frame: weeks 0, 8 and 12
|
Change in the European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L). The EQ-5D-5L can assess patients' quality of life, irrespective of the disease. It covers 5 dimensions of health (mobility, self-care, usual activities, pain or discomfort, and anxiety or depression) with 5 levels of severity in each dimension (no problems, slight problems, moderate problems, severe problems, and unable to perform or extreme problems). The descriptive system defines 3,125 distinct health-states. Responses can be combined in a form of a 5-digit number (the best state "11111" meaning no problems at any of dimension to the worst state "55555" meaning unable/extreme problems at all five dimensions). The second part of the instrument is a 20 cm visual analog scale (EQ VAS) ranging from 0 (worst health you can imagine) to 100 (best health you can imagine) |
weeks 0, 8 and 12
|
|
Satisfaction with life
Time Frame: weeks 0, 8 and 12
|
Change in the Satisfaction With Life Scale (SWLS). A 5-item scale designed to measure global cognitive judgments of one's life satisfaction (not a measure of either positive or negative affect). Participants indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 7 strongly agree to 1 strongly disagree. The five responses are summed to produce a total score for the scale. Total scores can, thus, range from a minimum of 5 to a maximum of 35. Higher scores indicate greater degrees of satisfaction with life. |
weeks 0, 8 and 12
|
|
Depressive symptoms
Time Frame: weeks 0, 8 and 12
|
Change in 5-item version of Yesavage's Geriatric Depression Scale (GDS-5).
This is useful for identify depressive symptoms among elder people.
The presence of 2 or more depressive symptoms is indicative of depression.
Higher scores indicate greater degrees of depressive symptoms.
|
weeks 0, 8 and 12
|
|
Social Support
Time Frame: weeks 0, 8 and 12
|
Change in the Lubben Social Network Scale (LSNS-6). It is a self-report measure of social engagement including family and friends. The total score is calculated by finding the sum of all items. the score ranges between 0 and 30, with a higher score indicating more social engagement It is a self-report measure of social engagement including family and friends. The total score is calculated by finding the sum of all items. the score ranges between 0 and 30, with a higher score indicating more social engagement |
weeks 0, 8 and 12
|
|
Communication
Time Frame: weeks 0, 8 and 12
|
Change in the Holden Communication Scale (HCS).
This is a scale of 12 items rated from 0 to 4 points completed by a professional based on observation of the person with dementia for a certain period of time.
It quantifies, based on the degree of deterioration, those aspects that relate the interrelation of the patient with his immediate environment, and the variables refer to observation, knowledge of reality and communication.
A higher score indicates greater impairment.
|
weeks 0, 8 and 12
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FSIE2024Robot
- 6773 (Other Identifier: CERec UAB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
Clinical Trials on Usual Care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of
-
Mayo ClinicCompleted
-
Centers for Disease Control and PreventionCompleted
-
Parc de Salut MarCompleted
-
Cairo UniversityCompletedChronic Obstructive Lung DiseaseEgypt